Stock Compensation (Tables)

12 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangement [Abstract]

Summary of stock option activity for the period

There were no options granted in 2024, 2023 and 2022. Options exercised in 2024, 2023 and 2022 were as follows:

Year	Options Exercised		Exercised Price
2024		102,468	$18.58 to $21.30
2023		62,551	$11.62 to $18.69
2022		83,102	$12.96 to $21.30

Options outstanding and exercisable at December 31, 2024, 2023 and 2022 were as follows:

Year	Outstanding		Range of Exercise Prices	Exercisable		Weighted Average Exercise Price
2024		16,114	$11.62 to $21.30		16,114	$	17.43
2023		118,602	$11.62 to $21.30		118,602	$	20.35
2022		224,882	$11.62 to $21.30		224,882	$	18.82

The following table provides a summary of stock option activity for the period ended December 31, 2024:

	Shares			Average Exercise Price		Weighted Average Life (in Years)
Outstanding at December 31, 2023		118,602		$	20.35
Options granted		—			—
Options exercised		(102,468	)		20.81
Canceled or forfeited		—			—
Expired		(20	)		20.93
Outstanding at December 31, 2024		16,114			17.43		2.63
Exercisable at December 31, 2024		16,114		$	17.43		2.63

Summary of combined restricted stock units, including performance-based restricted stock units and restricted stock activity for the period

The following table provides a summary of restricted stock units, including performance-based restricted stock units, and restricted stock activity for the year ended December 31, 2024:

	Shares			Average Grant-Date Fair Value
Unvested shares at December 31, 2023		845,711
Granted		535,127		$	19.23
Vested		(323,523	)	$	19.28
Canceled or forfeited		(113,460	)	$	20.05
Unvested shares at December 31, 2024		943,855